Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.

[1]  P. Barran,et al.  Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry , 2016, EuPA open proteomics.

[2]  J. Reichert.  Antibodies to watch in 2016 , 2016, mAbs.

[3]  François Debaene,et al.  Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates , 2016, Expert review of proteomics.

[4]  E. Belau,et al.  Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing , 2016, mAbs.

[5]  Davy Guillarme,et al.  Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals. , 2016, Analytical chemistry.

[6]  Jinming Li,et al.  Bispecific antibodies and their applications , 2015, Journal of Hematology & Oncology.

[7]  Michael Leiss,et al.  Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry , 2015, mAbs.

[8]  R. Hildenbrand,et al.  Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms. , 2015, The oncologist.

[9]  B. Ruotolo,et al.  Collision Induced Unfolding of Intact Antibodies: Rapid Characterization of Disulfide Bonding Patterns, Glycosylation, and Structures. , 2015, Analytical chemistry.

[10]  S. Cianférani,et al.  Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes. , 2015, The Analyst.

[11]  P. Carter,et al.  Alternative molecular formats and therapeutic applications for bispecific antibodies. , 2015, Molecular immunology.

[12]  F. Proux,et al.  Intermolecular recognition of the non-coding RNA 7SK and HEXIM protein in perspective. , 2015, Biochimie.

[13]  S. Cianférani,et al.  Combining native MS approaches to decipher archaeal box H/ACA ribonucleoprotein particle structure and activity , 2015, Proteomics.

[14]  A. Heck,et al.  Lysine conjugation properties in human IgGs studied by integrating high‐resolution native mass spectrometry and bottom‐up proteomics , 2015, Proteomics.

[15]  S. Cianférani,et al.  Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate , 2015, Protein science : a publication of the Protein Society.

[16]  Xiuling Li,et al.  Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. , 2015, Bioconjugate chemistry.

[17]  A. Plückthun,et al.  Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins. , 2015, Bioconjugate chemistry.

[18]  John F. Valliere-Douglass,et al.  Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry. , 2015, Molecular pharmaceutics.

[19]  P. Parren,et al.  Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector. , 2015, Analytical chemistry.

[20]  G. Klebe,et al.  What Glues a Homodimer Together: Systematic Analysis of the Stabilizing Effect of an Aromatic Hot Spot in the Protein-Protein Interface of the tRNA-Modifying Enzyme Tgt. , 2015, ACS chemical biology.

[21]  Tilman Schlothauer,et al.  Functional assessment of antibody oxidation by native mass spectrometry , 2015, mAbs.

[22]  J. Irving,et al.  An integrative approach combining ion mobility mass spectrometry, X-ray crystallography, and nuclear magnetic resonance spectroscopy to study the conformational dynamics of α1-antitrypsin upon ligand binding , 2015, Protein science : a publication of the Protein Society.

[23]  Alain Van Dorsselaer,et al.  Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. , 2015, Journal of mass spectrometry : JMS.

[24]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[25]  C. Robinson,et al.  Charge reduction stabilizes intact membrane protein complexes for mass spectrometry. , 2014, Journal of the American Chemical Society.

[26]  E. Ehrenpreis,et al.  Biosimilars: The Need, The Challenge, The Future: The FDA Perspective , 2014, The American Journal of Gastroenterology.

[27]  Alain Van Dorsselaer,et al.  Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. , 2014, Analytical chemistry.

[28]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[29]  Massimiliano Porrini,et al.  Dynamics of intact immunoglobulin G explored by drift-tube ion-mobility mass spectrometry and molecular modeling. , 2014, Angewandte Chemie.

[30]  Hannah J. Maple,et al.  Application of the Exactive Plus EMR for automated protein-ligand screening by non-covalent mass spectrometry. , 2014, Rapid communications in mass spectrometry : RCM.

[31]  A. Heck,et al.  Analytical approaches for size and mass analysis of large protein assemblies. , 2014, Annual review of analytical chemistry.

[32]  R. Chari,et al.  Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. , 2014, Journal of medicinal chemistry.

[33]  M. Quaglia,et al.  Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations. , 2014, Analytical Chemistry.

[34]  Argyris Politis,et al.  Mass spectrometry defines the C-terminal dimerization domain and enables modeling of the structure of full-length OmpA. , 2014, Structure.

[35]  A. Heck,et al.  Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry , 2014, Nature Protocols.

[36]  John F. Valliere-Douglass,et al.  Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry. , 2014, Analytical chemistry.

[37]  A. Beck,et al.  Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry. , 2014, Analytical chemistry.

[38]  Sandeep Kumar,et al.  Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry , 2014, Pharmaceutical Research.

[39]  Weidong Cui,et al.  Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies , 2014, FEBS letters.

[40]  Carol V. Robinson,et al.  Dynamic protein ligand interactions – insights from MS , 2014, The FEBS journal.

[41]  Natalie J. Thompson,et al.  Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry , 2014, mAbs.

[42]  J. Reichert,et al.  Antibody-drug conjugates , 2013, mAbs.

[43]  N. Kelleher,et al.  From protein complexes to subunit backbone fragments: a multi-stage approach to native mass spectrometry. , 2013, Analytical chemistry.

[44]  François Debaene,et al.  Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.

[45]  P. Parren,et al.  In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap , 2013, mAbs.

[46]  J. Reichert,et al.  Approval of the first biosimilar antibodies in Europe , 2013, mAbs.

[47]  John E. Johnson,et al.  Studying 18 MDa virus assemblies with native mass spectrometry. , 2013, Angewandte Chemie.

[48]  M. Gross,et al.  Complementary MS Methods Assist Conformational Characterization of Antibodies with Altered S–S Bonding Networks , 2013, Journal of The American Society for Mass Spectrometry.

[49]  Sheng Yin,et al.  Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates. , 2013, Analytical chemistry.

[50]  C. F. van der Walle,et al.  Therapeutic antibodies: market considerations, disease targets and bioprocessing. , 2013, International journal of pharmaceutics.

[51]  Natalie J. Thompson,et al.  Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. , 2012, Angewandte Chemie.

[52]  Albert J R Heck,et al.  High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies , 2012, Nature Methods.

[53]  Neil L. Kelleher,et al.  Analysis of Intact Monoclonal Antibody IgG1 by Electron Transfer Dissociation Orbitrap FTMS* , 2012, Molecular & Cellular Proteomics.

[54]  Stan J. J. Brouns,et al.  Native Tandem and Ion Mobility Mass Spectrometry Highlight Structural and Modular Similarities in Clustered-Regularly-Interspaced Shot-Palindromic-Repeats (CRISPR)-associated Protein Complexes From Escherichia coli and Pseudomonas aeruginosa* , 2012, Molecular & Cellular Proteomics.

[55]  P. Senter,et al.  The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma , 2012, Nature Biotechnology.

[56]  P. Barran,et al.  Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery. , 2012, Chemical Society reviews.

[57]  Alain Van Dorsselaer,et al.  Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. , 2012, Analytical chemistry.

[58]  John F. Valliere-Douglass,et al.  Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.

[59]  Lorna J. Smith,et al.  Charge-state dependent compaction and dissociation of protein complexes: insights from ion mobility and molecular dynamics. , 2012, Journal of the American Chemical Society.

[60]  A. Heck,et al.  Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. , 2012, Journal of structural biology.

[61]  John P. Gabrielson,et al.  In vitro stoichiometry of complexes between the soluble RANK ligand and the monoclonal antibody denosumab. , 2012, Biochemistry.

[62]  J. Reichert,et al.  World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA , 2012, mAbs.

[63]  P. Parren,et al.  Quantitative analysis of the interaction strength and dynamics of human IgG4 half molecules by native mass spectrometry. , 2011, Structure.

[64]  Yatin R. Gokarn,et al.  Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.

[65]  Christian Bailly,et al.  The next generation of antibody-drug conjugates comes of age. , 2010, Discovery medicine.

[66]  Vasco Filipe,et al.  Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography , 2010, Pharmaceutical Research.

[67]  P. Schnier,et al.  Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.

[68]  Albert J R Heck,et al.  Ion mobility mass spectrometry of proteins and protein assemblies. , 2010, Chemical Society reviews.

[69]  C. Robinson,et al.  Effects of antibody affinity and antigen valence on molecular forms of immune complexes. , 2009, Molecular immunology.

[70]  C. Damen,et al.  Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab , 2009, Journal of the American Society for Mass Spectrometry.

[71]  P. Parren,et al.  Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo , 2009, Nature Biotechnology.

[72]  A. van Dorsselaer,et al.  Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. , 2009, Analytical chemistry.

[73]  C. Robinson,et al.  Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes. , 2009, Chemistry & biology.

[74]  C. Scarff,et al.  Probing hemoglobin structure by means of traveling-wave ion mobility mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.

[75]  Carol V Robinson,et al.  Micelles Protect Membrane Complexes from Solution to Vacuum , 2008, Science.

[76]  M. Matsumura,et al.  Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. , 2008, Biochemistry.

[77]  Weibin Chen,et al.  Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[78]  C. Robinson,et al.  Regional and segmental flexibility of antibodies in interaction with antigens of different size , 2006, The FEBS journal.

[79]  C. Robinson,et al.  Evidence for Macromolecular Protein Rings in the Absence of Bulk Water , 2005, Science.

[80]  C. Robinson,et al.  Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach. , 2001, Biophysical journal.

[81]  M. Bowers,et al.  Gas-Phase Ion Chromatography: Transition Metal State Selection and Carbon Cluster Formation , 1993, Science.

[82]  B. Chait,et al.  Observation of the heme-globin complex in native myoglobin by electrospray-ionization mass spectrometry , 1991 .

[83]  B. Chait,et al.  Method for the electrospray ionization of highly conductive aqueous solutions. , 1991, Analytical chemistry.

[84]  P. Barran,et al.  Molecular Insights into the Thermal Stability of mAbs with Variable‐Temperature Ion‐Mobility Mass Spectrometry , 2016, Chembiochem : a European journal of chemical biology.

[85]  A. Glode,et al.  Blinatumomab: A novel, bispecific, T-cell engaging antibody. , 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[86]  Albert J R Heck,et al.  Performing native mass spectrometry analysis on therapeutic antibodies. , 2014, Methods.

[87]  P. Wingfield,et al.  Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids , 2013, Analytical and Bioanalytical Chemistry.

[88]  A. van Dorsselaer,et al.  Noncovalent mass spectrometry for the characterization of antibody/antigen complexes. , 2013, Methods in molecular biology.

[89]  A. Dorsselaer,et al.  Nondenaturing mass spectrometry to study noncovalent protein/protein and protein/ligand complexes: technical aspects and application to the determination of binding stoichiometries. , 2008, Methods in molecular biology.